| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.297 | 14.029 | 10.508 | 10.315 | 2.529 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 26.341 | 15.910 | 10.550 | 10.351 | 2.880 | 0 | 0 | 18 | 3.025 | 0 |
| Total Expenses - EUR | 18.588 | 3.545 | 3.174 | 352 | 28.409 | 3.355 | 1.142 | 681 | 3.196 | 231 |
| Gross Profit/Loss - EUR | 7.753 | 12.364 | 7.376 | 9.998 | -25.528 | -3.355 | -1.142 | -662 | -172 | -231 |
| Net Profit/Loss - EUR | 7.024 | 11.887 | 7.061 | 9.689 | -25.604 | -3.355 | -1.142 | -662 | -172 | -231 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cabinet Dr. Şutean Dan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 35.199 | 34.671 | 34.740 | 33.943 | 6.748 | 4.447 | 3.714 | 3.111 | 160 | 0 |
| Current Assets | 77.933 | 89.460 | 95.561 | 103.341 | 103.670 | 82.276 | 60.663 | 53.766 | 29.722 | 25.081 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 77.309 | 89.009 | 95.149 | 103.331 | 103.669 | 82.244 | 59.900 | 53.597 | 29.595 | 16.765 |
| Cash | 624 | 451 | 411 | 10 | 1 | 32 | 763 | 169 | 127 | 8.316 |
| Shareholders Funds | -7.294 | 4.667 | 11.649 | 21.125 | -4.889 | -8.151 | -9.112 | -9.803 | -9.945 | -10.120 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 120.426 | 119.464 | 118.652 | 116.159 | 115.306 | 94.874 | 73.489 | 66.680 | 39.826 | 35.201 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Cabinet Dr. Şutean Dan Srl